Global Hospital-Acquired Disease Testing Market 2024 by Company, Regions, Type and Application, Forecast to 2030
According to our (Global Info Research) latest study, the global Hospital-Acquired Disease Testing market size was valued at USD 506.5 million in 2023 and is forecast to a readjusted size of USD 711.6 million by 2030 with a CAGR of 5.0% during review period.
Hospital acquired infections/diseases (HAIs) or nosocomial infections are defined to the infection acquired by patients during their stay in healthcare settings. Approximately 9.2 out of 100 patients in the U.S. acquire HAI. The most common types of HAIs include pneumonia, urinary tract infection, bloodstream infection, surgical site infection and others. HAIs are caused by pathogens among patients with compromised immune system, and negligence by hospital staff. The significant morbidity and mortality, the associated management costs and growing pressure from governing bodies have urged care-givers to devise accurate diagnosis of HAIs for efficient healthcare provision.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
The Global Info Research report includes an overview of the development of the Hospital-Acquired Disease Testing industry chain, the market status of Small and Medium Sized Hospitals (UTI Testing, SSI Testing), Large Sized Hospitals (UTI Testing, SSI Testing), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Hospital-Acquired Disease Testing.
Regionally, the report analyzes the Hospital-Acquired Disease Testing markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Hospital-Acquired Disease Testing market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Hospital-Acquired Disease Testing market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Hospital-Acquired Disease Testing industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., UTI Testing, SSI Testing).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Hospital-Acquired Disease Testing market.
Regional Analysis: The report involves examining the Hospital-Acquired Disease Testing market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Hospital-Acquired Disease Testing market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Hospital-Acquired Disease Testing:
Company Analysis: Report covers individual Hospital-Acquired Disease Testing players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Hospital-Acquired Disease Testing This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Small and Medium Sized Hospitals, Large Sized Hospitals).
Technology Analysis: Report covers specific technologies relevant to Hospital-Acquired Disease Testing. It assesses the current state, advancements, and potential future developments in Hospital-Acquired Disease Testing areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Hospital-Acquired Disease Testing market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Hospital-Acquired Disease Testing market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Chapter 1, to describe Hospital-Acquired Disease Testing product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Hospital-Acquired Disease Testing, with revenue, gross margin and global market share of Hospital-Acquired Disease Testing from 2019 to 2024.
Chapter 3, the Hospital-Acquired Disease Testing competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Hospital-Acquired Disease Testing market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Hospital-Acquired Disease Testing.
Chapter 13, to describe Hospital-Acquired Disease Testing research findings and conclusion.
Hospital acquired infections/diseases (HAIs) or nosocomial infections are defined to the infection acquired by patients during their stay in healthcare settings. Approximately 9.2 out of 100 patients in the U.S. acquire HAI. The most common types of HAIs include pneumonia, urinary tract infection, bloodstream infection, surgical site infection and others. HAIs are caused by pathogens among patients with compromised immune system, and negligence by hospital staff. The significant morbidity and mortality, the associated management costs and growing pressure from governing bodies have urged care-givers to devise accurate diagnosis of HAIs for efficient healthcare provision.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
The Global Info Research report includes an overview of the development of the Hospital-Acquired Disease Testing industry chain, the market status of Small and Medium Sized Hospitals (UTI Testing, SSI Testing), Large Sized Hospitals (UTI Testing, SSI Testing), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Hospital-Acquired Disease Testing.
Regionally, the report analyzes the Hospital-Acquired Disease Testing markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Hospital-Acquired Disease Testing market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Hospital-Acquired Disease Testing market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Hospital-Acquired Disease Testing industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., UTI Testing, SSI Testing).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Hospital-Acquired Disease Testing market.
Regional Analysis: The report involves examining the Hospital-Acquired Disease Testing market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Hospital-Acquired Disease Testing market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Hospital-Acquired Disease Testing:
Company Analysis: Report covers individual Hospital-Acquired Disease Testing players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Hospital-Acquired Disease Testing This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Small and Medium Sized Hospitals, Large Sized Hospitals).
Technology Analysis: Report covers specific technologies relevant to Hospital-Acquired Disease Testing. It assesses the current state, advancements, and potential future developments in Hospital-Acquired Disease Testing areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Hospital-Acquired Disease Testing market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Hospital-Acquired Disease Testing market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
- UTI Testing
- SSI Testing
- Pneumococcal Infections Testing
- Bloodstream Infections Testing
- MRSA Testing
- Small and Medium Sized Hospitals
- Large Sized Hospitals
- Diatherix Laboratories
- Gen-Probe
- Qiagen
- F. Hoffmann-La Roche
- Cepheid
- Life Technologies Corporation
- Meridian Biosciences
- Cantel Medical Corporation
- Nordion
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
- South America (Brazil, Argentina and Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe Hospital-Acquired Disease Testing product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Hospital-Acquired Disease Testing, with revenue, gross margin and global market share of Hospital-Acquired Disease Testing from 2019 to 2024.
Chapter 3, the Hospital-Acquired Disease Testing competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Hospital-Acquired Disease Testing market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Hospital-Acquired Disease Testing.
Chapter 13, to describe Hospital-Acquired Disease Testing research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Hospital-Acquired Disease Testing
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Hospital-Acquired Disease Testing by Type
1.3.1 Overview: Global Hospital-Acquired Disease Testing Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Hospital-Acquired Disease Testing Consumption Value Market Share by Type in 2023
1.3.3 UTI Testing
1.3.4 SSI Testing
1.3.5 Pneumococcal Infections Testing
1.3.6 Bloodstream Infections Testing
1.3.7 MRSA Testing
1.4 Global Hospital-Acquired Disease Testing Market by Application
1.4.1 Overview: Global Hospital-Acquired Disease Testing Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Small and Medium Sized Hospitals
1.4.3 Large Sized Hospitals
1.5 Global Hospital-Acquired Disease Testing Market Size & Forecast
1.6 Global Hospital-Acquired Disease Testing Market Size and Forecast by Region
1.6.1 Global Hospital-Acquired Disease Testing Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Hospital-Acquired Disease Testing Market Size by Region, (2019-2030)
1.6.3 North America Hospital-Acquired Disease Testing Market Size and Prospect (2019-2030)
1.6.4 Europe Hospital-Acquired Disease Testing Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Hospital-Acquired Disease Testing Market Size and Prospect (2019-2030)
1.6.6 South America Hospital-Acquired Disease Testing Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Hospital-Acquired Disease Testing Market Size and Prospect (2019-2030)
2 COMPANY PROFILES
2.1 Diatherix Laboratories
2.1.1 Diatherix Laboratories Details
2.1.2 Diatherix Laboratories Major Business
2.1.3 Diatherix Laboratories Hospital-Acquired Disease Testing Product and Solutions
2.1.4 Diatherix Laboratories Hospital-Acquired Disease Testing Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Diatherix Laboratories Recent Developments and Future Plans
2.2 Gen-Probe
2.2.1 Gen-Probe Details
2.2.2 Gen-Probe Major Business
2.2.3 Gen-Probe Hospital-Acquired Disease Testing Product and Solutions
2.2.4 Gen-Probe Hospital-Acquired Disease Testing Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Gen-Probe Recent Developments and Future Plans
2.3 Qiagen
2.3.1 Qiagen Details
2.3.2 Qiagen Major Business
2.3.3 Qiagen Hospital-Acquired Disease Testing Product and Solutions
2.3.4 Qiagen Hospital-Acquired Disease Testing Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Qiagen Recent Developments and Future Plans
2.4 F. Hoffmann-La Roche
2.4.1 F. Hoffmann-La Roche Details
2.4.2 F. Hoffmann-La Roche Major Business
2.4.3 F. Hoffmann-La Roche Hospital-Acquired Disease Testing Product and Solutions
2.4.4 F. Hoffmann-La Roche Hospital-Acquired Disease Testing Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 F. Hoffmann-La Roche Recent Developments and Future Plans
2.5 Cepheid
2.5.1 Cepheid Details
2.5.2 Cepheid Major Business
2.5.3 Cepheid Hospital-Acquired Disease Testing Product and Solutions
2.5.4 Cepheid Hospital-Acquired Disease Testing Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Cepheid Recent Developments and Future Plans
2.6 Life Technologies Corporation
2.6.1 Life Technologies Corporation Details
2.6.2 Life Technologies Corporation Major Business
2.6.3 Life Technologies Corporation Hospital-Acquired Disease Testing Product and Solutions
2.6.4 Life Technologies Corporation Hospital-Acquired Disease Testing Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Life Technologies Corporation Recent Developments and Future Plans
2.7 Meridian Biosciences
2.7.1 Meridian Biosciences Details
2.7.2 Meridian Biosciences Major Business
2.7.3 Meridian Biosciences Hospital-Acquired Disease Testing Product and Solutions
2.7.4 Meridian Biosciences Hospital-Acquired Disease Testing Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Meridian Biosciences Recent Developments and Future Plans
2.8 Cantel Medical Corporation
2.8.1 Cantel Medical Corporation Details
2.8.2 Cantel Medical Corporation Major Business
2.8.3 Cantel Medical Corporation Hospital-Acquired Disease Testing Product and Solutions
2.8.4 Cantel Medical Corporation Hospital-Acquired Disease Testing Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Cantel Medical Corporation Recent Developments and Future Plans
2.9 Nordion
2.9.1 Nordion Details
2.9.2 Nordion Major Business
2.9.3 Nordion Hospital-Acquired Disease Testing Product and Solutions
2.9.4 Nordion Hospital-Acquired Disease Testing Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Nordion Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Hospital-Acquired Disease Testing Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Hospital-Acquired Disease Testing by Company Revenue
3.2.2 Top 3 Hospital-Acquired Disease Testing Players Market Share in 2023
3.2.3 Top 6 Hospital-Acquired Disease Testing Players Market Share in 2023
3.3 Hospital-Acquired Disease Testing Market: Overall Company Footprint Analysis
3.3.1 Hospital-Acquired Disease Testing Market: Region Footprint
3.3.2 Hospital-Acquired Disease Testing Market: Company Product Type Footprint
3.3.3 Hospital-Acquired Disease Testing Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Hospital-Acquired Disease Testing Consumption Value and Market Share by Type (2019-2024)
4.2 Global Hospital-Acquired Disease Testing Market Forecast by Type (2025-2030)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Hospital-Acquired Disease Testing Consumption Value Market Share by Application (2019-2024)
5.2 Global Hospital-Acquired Disease Testing Market Forecast by Application (2025-2030)
6 NORTH AMERICA
6.1 North America Hospital-Acquired Disease Testing Consumption Value by Type (2019-2030)
6.2 North America Hospital-Acquired Disease Testing Consumption Value by Application (2019-2030)
6.3 North America Hospital-Acquired Disease Testing Market Size by Country
6.3.1 North America Hospital-Acquired Disease Testing Consumption Value by Country (2019-2030)
6.3.2 United States Hospital-Acquired Disease Testing Market Size and Forecast (2019-2030)
6.3.3 Canada Hospital-Acquired Disease Testing Market Size and Forecast (2019-2030)
6.3.4 Mexico Hospital-Acquired Disease Testing Market Size and Forecast (2019-2030)
7 EUROPE
7.1 Europe Hospital-Acquired Disease Testing Consumption Value by Type (2019-2030)
7.2 Europe Hospital-Acquired Disease Testing Consumption Value by Application (2019-2030)
7.3 Europe Hospital-Acquired Disease Testing Market Size by Country
7.3.1 Europe Hospital-Acquired Disease Testing Consumption Value by Country (2019-2030)
7.3.2 Germany Hospital-Acquired Disease Testing Market Size and Forecast (2019-2030)
7.3.3 France Hospital-Acquired Disease Testing Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Hospital-Acquired Disease Testing Market Size and Forecast (2019-2030)
7.3.5 Russia Hospital-Acquired Disease Testing Market Size and Forecast (2019-2030)
7.3.6 Italy Hospital-Acquired Disease Testing Market Size and Forecast (2019-2030)
8 ASIA-PACIFIC
8.1 Asia-Pacific Hospital-Acquired Disease Testing Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Hospital-Acquired Disease Testing Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Hospital-Acquired Disease Testing Market Size by Region
8.3.1 Asia-Pacific Hospital-Acquired Disease Testing Consumption Value by Region (2019-2030)
8.3.2 China Hospital-Acquired Disease Testing Market Size and Forecast (2019-2030)
8.3.3 Japan Hospital-Acquired Disease Testing Market Size and Forecast (2019-2030)
8.3.4 South Korea Hospital-Acquired Disease Testing Market Size and Forecast (2019-2030)
8.3.5 India Hospital-Acquired Disease Testing Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Hospital-Acquired Disease Testing Market Size and Forecast (2019-2030)
8.3.7 Australia Hospital-Acquired Disease Testing Market Size and Forecast (2019-2030)
9 SOUTH AMERICA
9.1 South America Hospital-Acquired Disease Testing Consumption Value by Type (2019-2030)
9.2 South America Hospital-Acquired Disease Testing Consumption Value by Application (2019-2030)
9.3 South America Hospital-Acquired Disease Testing Market Size by Country
9.3.1 South America Hospital-Acquired Disease Testing Consumption Value by Country (2019-2030)
9.3.2 Brazil Hospital-Acquired Disease Testing Market Size and Forecast (2019-2030)
9.3.3 Argentina Hospital-Acquired Disease Testing Market Size and Forecast (2019-2030)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Hospital-Acquired Disease Testing Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Hospital-Acquired Disease Testing Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Hospital-Acquired Disease Testing Market Size by Country
10.3.1 Middle East & Africa Hospital-Acquired Disease Testing Consumption Value by Country (2019-2030)
10.3.2 Turkey Hospital-Acquired Disease Testing Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Hospital-Acquired Disease Testing Market Size and Forecast (2019-2030)
10.3.4 UAE Hospital-Acquired Disease Testing Market Size and Forecast (2019-2030)
11 MARKET DYNAMICS
11.1 Hospital-Acquired Disease Testing Market Drivers
11.2 Hospital-Acquired Disease Testing Market Restraints
11.3 Hospital-Acquired Disease Testing Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Hospital-Acquired Disease Testing Industry Chain
12.2 Hospital-Acquired Disease Testing Upstream Analysis
12.3 Hospital-Acquired Disease Testing Midstream Analysis
12.4 Hospital-Acquired Disease Testing Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope of Hospital-Acquired Disease Testing
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Hospital-Acquired Disease Testing by Type
1.3.1 Overview: Global Hospital-Acquired Disease Testing Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Hospital-Acquired Disease Testing Consumption Value Market Share by Type in 2023
1.3.3 UTI Testing
1.3.4 SSI Testing
1.3.5 Pneumococcal Infections Testing
1.3.6 Bloodstream Infections Testing
1.3.7 MRSA Testing
1.4 Global Hospital-Acquired Disease Testing Market by Application
1.4.1 Overview: Global Hospital-Acquired Disease Testing Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Small and Medium Sized Hospitals
1.4.3 Large Sized Hospitals
1.5 Global Hospital-Acquired Disease Testing Market Size & Forecast
1.6 Global Hospital-Acquired Disease Testing Market Size and Forecast by Region
1.6.1 Global Hospital-Acquired Disease Testing Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Hospital-Acquired Disease Testing Market Size by Region, (2019-2030)
1.6.3 North America Hospital-Acquired Disease Testing Market Size and Prospect (2019-2030)
1.6.4 Europe Hospital-Acquired Disease Testing Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Hospital-Acquired Disease Testing Market Size and Prospect (2019-2030)
1.6.6 South America Hospital-Acquired Disease Testing Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Hospital-Acquired Disease Testing Market Size and Prospect (2019-2030)
2 COMPANY PROFILES
2.1 Diatherix Laboratories
2.1.1 Diatherix Laboratories Details
2.1.2 Diatherix Laboratories Major Business
2.1.3 Diatherix Laboratories Hospital-Acquired Disease Testing Product and Solutions
2.1.4 Diatherix Laboratories Hospital-Acquired Disease Testing Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Diatherix Laboratories Recent Developments and Future Plans
2.2 Gen-Probe
2.2.1 Gen-Probe Details
2.2.2 Gen-Probe Major Business
2.2.3 Gen-Probe Hospital-Acquired Disease Testing Product and Solutions
2.2.4 Gen-Probe Hospital-Acquired Disease Testing Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Gen-Probe Recent Developments and Future Plans
2.3 Qiagen
2.3.1 Qiagen Details
2.3.2 Qiagen Major Business
2.3.3 Qiagen Hospital-Acquired Disease Testing Product and Solutions
2.3.4 Qiagen Hospital-Acquired Disease Testing Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Qiagen Recent Developments and Future Plans
2.4 F. Hoffmann-La Roche
2.4.1 F. Hoffmann-La Roche Details
2.4.2 F. Hoffmann-La Roche Major Business
2.4.3 F. Hoffmann-La Roche Hospital-Acquired Disease Testing Product and Solutions
2.4.4 F. Hoffmann-La Roche Hospital-Acquired Disease Testing Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 F. Hoffmann-La Roche Recent Developments and Future Plans
2.5 Cepheid
2.5.1 Cepheid Details
2.5.2 Cepheid Major Business
2.5.3 Cepheid Hospital-Acquired Disease Testing Product and Solutions
2.5.4 Cepheid Hospital-Acquired Disease Testing Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Cepheid Recent Developments and Future Plans
2.6 Life Technologies Corporation
2.6.1 Life Technologies Corporation Details
2.6.2 Life Technologies Corporation Major Business
2.6.3 Life Technologies Corporation Hospital-Acquired Disease Testing Product and Solutions
2.6.4 Life Technologies Corporation Hospital-Acquired Disease Testing Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Life Technologies Corporation Recent Developments and Future Plans
2.7 Meridian Biosciences
2.7.1 Meridian Biosciences Details
2.7.2 Meridian Biosciences Major Business
2.7.3 Meridian Biosciences Hospital-Acquired Disease Testing Product and Solutions
2.7.4 Meridian Biosciences Hospital-Acquired Disease Testing Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Meridian Biosciences Recent Developments and Future Plans
2.8 Cantel Medical Corporation
2.8.1 Cantel Medical Corporation Details
2.8.2 Cantel Medical Corporation Major Business
2.8.3 Cantel Medical Corporation Hospital-Acquired Disease Testing Product and Solutions
2.8.4 Cantel Medical Corporation Hospital-Acquired Disease Testing Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Cantel Medical Corporation Recent Developments and Future Plans
2.9 Nordion
2.9.1 Nordion Details
2.9.2 Nordion Major Business
2.9.3 Nordion Hospital-Acquired Disease Testing Product and Solutions
2.9.4 Nordion Hospital-Acquired Disease Testing Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Nordion Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Hospital-Acquired Disease Testing Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Hospital-Acquired Disease Testing by Company Revenue
3.2.2 Top 3 Hospital-Acquired Disease Testing Players Market Share in 2023
3.2.3 Top 6 Hospital-Acquired Disease Testing Players Market Share in 2023
3.3 Hospital-Acquired Disease Testing Market: Overall Company Footprint Analysis
3.3.1 Hospital-Acquired Disease Testing Market: Region Footprint
3.3.2 Hospital-Acquired Disease Testing Market: Company Product Type Footprint
3.3.3 Hospital-Acquired Disease Testing Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Hospital-Acquired Disease Testing Consumption Value and Market Share by Type (2019-2024)
4.2 Global Hospital-Acquired Disease Testing Market Forecast by Type (2025-2030)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Hospital-Acquired Disease Testing Consumption Value Market Share by Application (2019-2024)
5.2 Global Hospital-Acquired Disease Testing Market Forecast by Application (2025-2030)
6 NORTH AMERICA
6.1 North America Hospital-Acquired Disease Testing Consumption Value by Type (2019-2030)
6.2 North America Hospital-Acquired Disease Testing Consumption Value by Application (2019-2030)
6.3 North America Hospital-Acquired Disease Testing Market Size by Country
6.3.1 North America Hospital-Acquired Disease Testing Consumption Value by Country (2019-2030)
6.3.2 United States Hospital-Acquired Disease Testing Market Size and Forecast (2019-2030)
6.3.3 Canada Hospital-Acquired Disease Testing Market Size and Forecast (2019-2030)
6.3.4 Mexico Hospital-Acquired Disease Testing Market Size and Forecast (2019-2030)
7 EUROPE
7.1 Europe Hospital-Acquired Disease Testing Consumption Value by Type (2019-2030)
7.2 Europe Hospital-Acquired Disease Testing Consumption Value by Application (2019-2030)
7.3 Europe Hospital-Acquired Disease Testing Market Size by Country
7.3.1 Europe Hospital-Acquired Disease Testing Consumption Value by Country (2019-2030)
7.3.2 Germany Hospital-Acquired Disease Testing Market Size and Forecast (2019-2030)
7.3.3 France Hospital-Acquired Disease Testing Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Hospital-Acquired Disease Testing Market Size and Forecast (2019-2030)
7.3.5 Russia Hospital-Acquired Disease Testing Market Size and Forecast (2019-2030)
7.3.6 Italy Hospital-Acquired Disease Testing Market Size and Forecast (2019-2030)
8 ASIA-PACIFIC
8.1 Asia-Pacific Hospital-Acquired Disease Testing Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Hospital-Acquired Disease Testing Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Hospital-Acquired Disease Testing Market Size by Region
8.3.1 Asia-Pacific Hospital-Acquired Disease Testing Consumption Value by Region (2019-2030)
8.3.2 China Hospital-Acquired Disease Testing Market Size and Forecast (2019-2030)
8.3.3 Japan Hospital-Acquired Disease Testing Market Size and Forecast (2019-2030)
8.3.4 South Korea Hospital-Acquired Disease Testing Market Size and Forecast (2019-2030)
8.3.5 India Hospital-Acquired Disease Testing Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Hospital-Acquired Disease Testing Market Size and Forecast (2019-2030)
8.3.7 Australia Hospital-Acquired Disease Testing Market Size and Forecast (2019-2030)
9 SOUTH AMERICA
9.1 South America Hospital-Acquired Disease Testing Consumption Value by Type (2019-2030)
9.2 South America Hospital-Acquired Disease Testing Consumption Value by Application (2019-2030)
9.3 South America Hospital-Acquired Disease Testing Market Size by Country
9.3.1 South America Hospital-Acquired Disease Testing Consumption Value by Country (2019-2030)
9.3.2 Brazil Hospital-Acquired Disease Testing Market Size and Forecast (2019-2030)
9.3.3 Argentina Hospital-Acquired Disease Testing Market Size and Forecast (2019-2030)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Hospital-Acquired Disease Testing Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Hospital-Acquired Disease Testing Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Hospital-Acquired Disease Testing Market Size by Country
10.3.1 Middle East & Africa Hospital-Acquired Disease Testing Consumption Value by Country (2019-2030)
10.3.2 Turkey Hospital-Acquired Disease Testing Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Hospital-Acquired Disease Testing Market Size and Forecast (2019-2030)
10.3.4 UAE Hospital-Acquired Disease Testing Market Size and Forecast (2019-2030)
11 MARKET DYNAMICS
11.1 Hospital-Acquired Disease Testing Market Drivers
11.2 Hospital-Acquired Disease Testing Market Restraints
11.3 Hospital-Acquired Disease Testing Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Hospital-Acquired Disease Testing Industry Chain
12.2 Hospital-Acquired Disease Testing Upstream Analysis
12.3 Hospital-Acquired Disease Testing Midstream Analysis
12.4 Hospital-Acquired Disease Testing Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Hospital-Acquired Disease Testing Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Hospital-Acquired Disease Testing Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global Hospital-Acquired Disease Testing Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Hospital-Acquired Disease Testing Consumption Value by Region (2025-2030) & (USD Million)
Table 5. Diatherix Laboratories Company Information, Head Office, and Major Competitors
Table 6. Diatherix Laboratories Major Business
Table 7. Diatherix Laboratories Hospital-Acquired Disease Testing Product and Solutions
Table 8. Diatherix Laboratories Hospital-Acquired Disease Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. Diatherix Laboratories Recent Developments and Future Plans
Table 10. Gen-Probe Company Information, Head Office, and Major Competitors
Table 11. Gen-Probe Major Business
Table 12. Gen-Probe Hospital-Acquired Disease Testing Product and Solutions
Table 13. Gen-Probe Hospital-Acquired Disease Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Gen-Probe Recent Developments and Future Plans
Table 15. Qiagen Company Information, Head Office, and Major Competitors
Table 16. Qiagen Major Business
Table 17. Qiagen Hospital-Acquired Disease Testing Product and Solutions
Table 18. Qiagen Hospital-Acquired Disease Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. Qiagen Recent Developments and Future Plans
Table 20. F. Hoffmann-La Roche Company Information, Head Office, and Major Competitors
Table 21. F. Hoffmann-La Roche Major Business
Table 22. F. Hoffmann-La Roche Hospital-Acquired Disease Testing Product and Solutions
Table 23. F. Hoffmann-La Roche Hospital-Acquired Disease Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. F. Hoffmann-La Roche Recent Developments and Future Plans
Table 25. Cepheid Company Information, Head Office, and Major Competitors
Table 26. Cepheid Major Business
Table 27. Cepheid Hospital-Acquired Disease Testing Product and Solutions
Table 28. Cepheid Hospital-Acquired Disease Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. Cepheid Recent Developments and Future Plans
Table 30. Life Technologies Corporation Company Information, Head Office, and Major Competitors
Table 31. Life Technologies Corporation Major Business
Table 32. Life Technologies Corporation Hospital-Acquired Disease Testing Product and Solutions
Table 33. Life Technologies Corporation Hospital-Acquired Disease Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. Life Technologies Corporation Recent Developments and Future Plans
Table 35. Meridian Biosciences Company Information, Head Office, and Major Competitors
Table 36. Meridian Biosciences Major Business
Table 37. Meridian Biosciences Hospital-Acquired Disease Testing Product and Solutions
Table 38. Meridian Biosciences Hospital-Acquired Disease Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. Meridian Biosciences Recent Developments and Future Plans
Table 40. Cantel Medical Corporation Company Information, Head Office, and Major Competitors
Table 41. Cantel Medical Corporation Major Business
Table 42. Cantel Medical Corporation Hospital-Acquired Disease Testing Product and Solutions
Table 43. Cantel Medical Corporation Hospital-Acquired Disease Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. Cantel Medical Corporation Recent Developments and Future Plans
Table 45. Nordion Company Information, Head Office, and Major Competitors
Table 46. Nordion Major Business
Table 47. Nordion Hospital-Acquired Disease Testing Product and Solutions
Table 48. Nordion Hospital-Acquired Disease Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 49. Nordion Recent Developments and Future Plans
Table 50. Global Hospital-Acquired Disease Testing Revenue (USD Million) by Players (2019-2024)
Table 51. Global Hospital-Acquired Disease Testing Revenue Share by Players (2019-2024)
Table 52. Breakdown of Hospital-Acquired Disease Testing by Company Type (Tier 1, Tier 2, and Tier 3)
Table 53. Market Position of Players in Hospital-Acquired Disease Testing, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 54. Head Office of Key Hospital-Acquired Disease Testing Players
Table 55. Hospital-Acquired Disease Testing Market: Company Product Type Footprint
Table 56. Hospital-Acquired Disease Testing Market: Company Product Application Footprint
Table 57. Hospital-Acquired Disease Testing New Market Entrants and Barriers to Market Entry
Table 58. Hospital-Acquired Disease Testing Mergers, Acquisition, Agreements, and Collaborations
Table 59. Global Hospital-Acquired Disease Testing Consumption Value (USD Million) by Type (2019-2024)
Table 60. Global Hospital-Acquired Disease Testing Consumption Value Share by Type (2019-2024)
Table 61. Global Hospital-Acquired Disease Testing Consumption Value Forecast by Type (2025-2030)
Table 62. Global Hospital-Acquired Disease Testing Consumption Value by Application (2019-2024)
Table 63. Global Hospital-Acquired Disease Testing Consumption Value Forecast by Application (2025-2030)
Table 64. North America Hospital-Acquired Disease Testing Consumption Value by Type (2019-2024) & (USD Million)
Table 65. North America Hospital-Acquired Disease Testing Consumption Value by Type (2025-2030) & (USD Million)
Table 66. North America Hospital-Acquired Disease Testing Consumption Value by Application (2019-2024) & (USD Million)
Table 67. North America Hospital-Acquired Disease Testing Consumption Value by Application (2025-2030) & (USD Million)
Table 68. North America Hospital-Acquired Disease Testing Consumption Value by Country (2019-2024) & (USD Million)
Table 69. North America Hospital-Acquired Disease Testing Consumption Value by Country (2025-2030) & (USD Million)
Table 70. Europe Hospital-Acquired Disease Testing Consumption Value by Type (2019-2024) & (USD Million)
Table 71. Europe Hospital-Acquired Disease Testing Consumption Value by Type (2025-2030) & (USD Million)
Table 72. Europe Hospital-Acquired Disease Testing Consumption Value by Application (2019-2024) & (USD Million)
Table 73. Europe Hospital-Acquired Disease Testing Consumption Value by Application (2025-2030) & (USD Million)
Table 74. Europe Hospital-Acquired Disease Testing Consumption Value by Country (2019-2024) & (USD Million)
Table 75. Europe Hospital-Acquired Disease Testing Consumption Value by Country (2025-2030) & (USD Million)
Table 76. Asia-Pacific Hospital-Acquired Disease Testing Consumption Value by Type (2019-2024) & (USD Million)
Table 77. Asia-Pacific Hospital-Acquired Disease Testing Consumption Value by Type (2025-2030) & (USD Million)
Table 78. Asia-Pacific Hospital-Acquired Disease Testing Consumption Value by Application (2019-2024) & (USD Million)
Table 79. Asia-Pacific Hospital-Acquired Disease Testing Consumption Value by Application (2025-2030) & (USD Million)
Table 80. Asia-Pacific Hospital-Acquired Disease Testing Consumption Value by Region (2019-2024) & (USD Million)
Table 81. Asia-Pacific Hospital-Acquired Disease Testing Consumption Value by Region (2025-2030) & (USD Million)
Table 82. South America Hospital-Acquired Disease Testing Consumption Value by Type (2019-2024) & (USD Million)
Table 83. South America Hospital-Acquired Disease Testing Consumption Value by Type (2025-2030) & (USD Million)
Table 84. South America Hospital-Acquired Disease Testing Consumption Value by Application (2019-2024) & (USD Million)
Table 85. South America Hospital-Acquired Disease Testing Consumption Value by Application (2025-2030) & (USD Million)
Table 86. South America Hospital-Acquired Disease Testing Consumption Value by Country (2019-2024) & (USD Million)
Table 87. South America Hospital-Acquired Disease Testing Consumption Value by Country (2025-2030) & (USD Million)
Table 88. Middle East & Africa Hospital-Acquired Disease Testing Consumption Value by Type (2019-2024) & (USD Million)
Table 89. Middle East & Africa Hospital-Acquired Disease Testing Consumption Value by Type (2025-2030) & (USD Million)
Table 90. Middle East & Africa Hospital-Acquired Disease Testing Consumption Value by Application (2019-2024) & (USD Million)
Table 91. Middle East & Africa Hospital-Acquired Disease Testing Consumption Value by Application (2025-2030) & (USD Million)
Table 92. Middle East & Africa Hospital-Acquired Disease Testing Consumption Value by Country (2019-2024) & (USD Million)
Table 93. Middle East & Africa Hospital-Acquired Disease Testing Consumption Value by Country (2025-2030) & (USD Million)
Table 94. Hospital-Acquired Disease Testing Raw Material
Table 95. Key Suppliers of Hospital-Acquired Disease Testing Raw Materials
Table 1. Global Hospital-Acquired Disease Testing Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Hospital-Acquired Disease Testing Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global Hospital-Acquired Disease Testing Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Hospital-Acquired Disease Testing Consumption Value by Region (2025-2030) & (USD Million)
Table 5. Diatherix Laboratories Company Information, Head Office, and Major Competitors
Table 6. Diatherix Laboratories Major Business
Table 7. Diatherix Laboratories Hospital-Acquired Disease Testing Product and Solutions
Table 8. Diatherix Laboratories Hospital-Acquired Disease Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. Diatherix Laboratories Recent Developments and Future Plans
Table 10. Gen-Probe Company Information, Head Office, and Major Competitors
Table 11. Gen-Probe Major Business
Table 12. Gen-Probe Hospital-Acquired Disease Testing Product and Solutions
Table 13. Gen-Probe Hospital-Acquired Disease Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Gen-Probe Recent Developments and Future Plans
Table 15. Qiagen Company Information, Head Office, and Major Competitors
Table 16. Qiagen Major Business
Table 17. Qiagen Hospital-Acquired Disease Testing Product and Solutions
Table 18. Qiagen Hospital-Acquired Disease Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. Qiagen Recent Developments and Future Plans
Table 20. F. Hoffmann-La Roche Company Information, Head Office, and Major Competitors
Table 21. F. Hoffmann-La Roche Major Business
Table 22. F. Hoffmann-La Roche Hospital-Acquired Disease Testing Product and Solutions
Table 23. F. Hoffmann-La Roche Hospital-Acquired Disease Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. F. Hoffmann-La Roche Recent Developments and Future Plans
Table 25. Cepheid Company Information, Head Office, and Major Competitors
Table 26. Cepheid Major Business
Table 27. Cepheid Hospital-Acquired Disease Testing Product and Solutions
Table 28. Cepheid Hospital-Acquired Disease Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. Cepheid Recent Developments and Future Plans
Table 30. Life Technologies Corporation Company Information, Head Office, and Major Competitors
Table 31. Life Technologies Corporation Major Business
Table 32. Life Technologies Corporation Hospital-Acquired Disease Testing Product and Solutions
Table 33. Life Technologies Corporation Hospital-Acquired Disease Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. Life Technologies Corporation Recent Developments and Future Plans
Table 35. Meridian Biosciences Company Information, Head Office, and Major Competitors
Table 36. Meridian Biosciences Major Business
Table 37. Meridian Biosciences Hospital-Acquired Disease Testing Product and Solutions
Table 38. Meridian Biosciences Hospital-Acquired Disease Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. Meridian Biosciences Recent Developments and Future Plans
Table 40. Cantel Medical Corporation Company Information, Head Office, and Major Competitors
Table 41. Cantel Medical Corporation Major Business
Table 42. Cantel Medical Corporation Hospital-Acquired Disease Testing Product and Solutions
Table 43. Cantel Medical Corporation Hospital-Acquired Disease Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. Cantel Medical Corporation Recent Developments and Future Plans
Table 45. Nordion Company Information, Head Office, and Major Competitors
Table 46. Nordion Major Business
Table 47. Nordion Hospital-Acquired Disease Testing Product and Solutions
Table 48. Nordion Hospital-Acquired Disease Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 49. Nordion Recent Developments and Future Plans
Table 50. Global Hospital-Acquired Disease Testing Revenue (USD Million) by Players (2019-2024)
Table 51. Global Hospital-Acquired Disease Testing Revenue Share by Players (2019-2024)
Table 52. Breakdown of Hospital-Acquired Disease Testing by Company Type (Tier 1, Tier 2, and Tier 3)
Table 53. Market Position of Players in Hospital-Acquired Disease Testing, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 54. Head Office of Key Hospital-Acquired Disease Testing Players
Table 55. Hospital-Acquired Disease Testing Market: Company Product Type Footprint
Table 56. Hospital-Acquired Disease Testing Market: Company Product Application Footprint
Table 57. Hospital-Acquired Disease Testing New Market Entrants and Barriers to Market Entry
Table 58. Hospital-Acquired Disease Testing Mergers, Acquisition, Agreements, and Collaborations
Table 59. Global Hospital-Acquired Disease Testing Consumption Value (USD Million) by Type (2019-2024)
Table 60. Global Hospital-Acquired Disease Testing Consumption Value Share by Type (2019-2024)
Table 61. Global Hospital-Acquired Disease Testing Consumption Value Forecast by Type (2025-2030)
Table 62. Global Hospital-Acquired Disease Testing Consumption Value by Application (2019-2024)
Table 63. Global Hospital-Acquired Disease Testing Consumption Value Forecast by Application (2025-2030)
Table 64. North America Hospital-Acquired Disease Testing Consumption Value by Type (2019-2024) & (USD Million)
Table 65. North America Hospital-Acquired Disease Testing Consumption Value by Type (2025-2030) & (USD Million)
Table 66. North America Hospital-Acquired Disease Testing Consumption Value by Application (2019-2024) & (USD Million)
Table 67. North America Hospital-Acquired Disease Testing Consumption Value by Application (2025-2030) & (USD Million)
Table 68. North America Hospital-Acquired Disease Testing Consumption Value by Country (2019-2024) & (USD Million)
Table 69. North America Hospital-Acquired Disease Testing Consumption Value by Country (2025-2030) & (USD Million)
Table 70. Europe Hospital-Acquired Disease Testing Consumption Value by Type (2019-2024) & (USD Million)
Table 71. Europe Hospital-Acquired Disease Testing Consumption Value by Type (2025-2030) & (USD Million)
Table 72. Europe Hospital-Acquired Disease Testing Consumption Value by Application (2019-2024) & (USD Million)
Table 73. Europe Hospital-Acquired Disease Testing Consumption Value by Application (2025-2030) & (USD Million)
Table 74. Europe Hospital-Acquired Disease Testing Consumption Value by Country (2019-2024) & (USD Million)
Table 75. Europe Hospital-Acquired Disease Testing Consumption Value by Country (2025-2030) & (USD Million)
Table 76. Asia-Pacific Hospital-Acquired Disease Testing Consumption Value by Type (2019-2024) & (USD Million)
Table 77. Asia-Pacific Hospital-Acquired Disease Testing Consumption Value by Type (2025-2030) & (USD Million)
Table 78. Asia-Pacific Hospital-Acquired Disease Testing Consumption Value by Application (2019-2024) & (USD Million)
Table 79. Asia-Pacific Hospital-Acquired Disease Testing Consumption Value by Application (2025-2030) & (USD Million)
Table 80. Asia-Pacific Hospital-Acquired Disease Testing Consumption Value by Region (2019-2024) & (USD Million)
Table 81. Asia-Pacific Hospital-Acquired Disease Testing Consumption Value by Region (2025-2030) & (USD Million)
Table 82. South America Hospital-Acquired Disease Testing Consumption Value by Type (2019-2024) & (USD Million)
Table 83. South America Hospital-Acquired Disease Testing Consumption Value by Type (2025-2030) & (USD Million)
Table 84. South America Hospital-Acquired Disease Testing Consumption Value by Application (2019-2024) & (USD Million)
Table 85. South America Hospital-Acquired Disease Testing Consumption Value by Application (2025-2030) & (USD Million)
Table 86. South America Hospital-Acquired Disease Testing Consumption Value by Country (2019-2024) & (USD Million)
Table 87. South America Hospital-Acquired Disease Testing Consumption Value by Country (2025-2030) & (USD Million)
Table 88. Middle East & Africa Hospital-Acquired Disease Testing Consumption Value by Type (2019-2024) & (USD Million)
Table 89. Middle East & Africa Hospital-Acquired Disease Testing Consumption Value by Type (2025-2030) & (USD Million)
Table 90. Middle East & Africa Hospital-Acquired Disease Testing Consumption Value by Application (2019-2024) & (USD Million)
Table 91. Middle East & Africa Hospital-Acquired Disease Testing Consumption Value by Application (2025-2030) & (USD Million)
Table 92. Middle East & Africa Hospital-Acquired Disease Testing Consumption Value by Country (2019-2024) & (USD Million)
Table 93. Middle East & Africa Hospital-Acquired Disease Testing Consumption Value by Country (2025-2030) & (USD Million)
Table 94. Hospital-Acquired Disease Testing Raw Material
Table 95. Key Suppliers of Hospital-Acquired Disease Testing Raw Materials
LIST OF FIGURES
Figure 1. Hospital-Acquired Disease Testing Picture
Figure 2. Global Hospital-Acquired Disease Testing Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Hospital-Acquired Disease Testing Consumption Value Market Share by Type in 2023
Figure 4. UTI Testing
Figure 5. SSI Testing
Figure 6. Pneumococcal Infections Testing
Figure 7. Bloodstream Infections Testing
Figure 8. MRSA Testing
Figure 9. Global Hospital-Acquired Disease Testing Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 10. Hospital-Acquired Disease Testing Consumption Value Market Share by Application in 2023
Figure 11. Small and Medium Sized Hospitals Picture
Figure 12. Large Sized Hospitals Picture
Figure 13. Global Hospital-Acquired Disease Testing Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 14. Global Hospital-Acquired Disease Testing Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 15. Global Market Hospital-Acquired Disease Testing Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 16. Global Hospital-Acquired Disease Testing Consumption Value Market Share by Region (2019-2030)
Figure 17. Global Hospital-Acquired Disease Testing Consumption Value Market Share by Region in 2023
Figure 18. North America Hospital-Acquired Disease Testing Consumption Value (2019-2030) & (USD Million)
Figure 19. Europe Hospital-Acquired Disease Testing Consumption Value (2019-2030) & (USD Million)
Figure 20. Asia-Pacific Hospital-Acquired Disease Testing Consumption Value (2019-2030) & (USD Million)
Figure 21. South America Hospital-Acquired Disease Testing Consumption Value (2019-2030) & (USD Million)
Figure 22. Middle East and Africa Hospital-Acquired Disease Testing Consumption Value (2019-2030) & (USD Million)
Figure 23. Global Hospital-Acquired Disease Testing Revenue Share by Players in 2023
Figure 24. Hospital-Acquired Disease Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 25. Global Top 3 Players Hospital-Acquired Disease Testing Market Share in 2023
Figure 26. Global Top 6 Players Hospital-Acquired Disease Testing Market Share in 2023
Figure 27. Global Hospital-Acquired Disease Testing Consumption Value Share by Type (2019-2024)
Figure 28. Global Hospital-Acquired Disease Testing Market Share Forecast by Type (2025-2030)
Figure 29. Global Hospital-Acquired Disease Testing Consumption Value Share by Application (2019-2024)
Figure 30. Global Hospital-Acquired Disease Testing Market Share Forecast by Application (2025-2030)
Figure 31. North America Hospital-Acquired Disease Testing Consumption Value Market Share by Type (2019-2030)
Figure 32. North America Hospital-Acquired Disease Testing Consumption Value Market Share by Application (2019-2030)
Figure 33. North America Hospital-Acquired Disease Testing Consumption Value Market Share by Country (2019-2030)
Figure 34. United States Hospital-Acquired Disease Testing Consumption Value (2019-2030) & (USD Million)
Figure 35. Canada Hospital-Acquired Disease Testing Consumption Value (2019-2030) & (USD Million)
Figure 36. Mexico Hospital-Acquired Disease Testing Consumption Value (2019-2030) & (USD Million)
Figure 37. Europe Hospital-Acquired Disease Testing Consumption Value Market Share by Type (2019-2030)
Figure 38. Europe Hospital-Acquired Disease Testing Consumption Value Market Share by Application (2019-2030)
Figure 39. Europe Hospital-Acquired Disease Testing Consumption Value Market Share by Country (2019-2030)
Figure 40. Germany Hospital-Acquired Disease Testing Consumption Value (2019-2030) & (USD Million)
Figure 41. France Hospital-Acquired Disease Testing Consumption Value (2019-2030) & (USD Million)
Figure 42. United Kingdom Hospital-Acquired Disease Testing Consumption Value (2019-2030) & (USD Million)
Figure 43. Russia Hospital-Acquired Disease Testing Consumption Value (2019-2030) & (USD Million)
Figure 44. Italy Hospital-Acquired Disease Testing Consumption Value (2019-2030) & (USD Million)
Figure 45. Asia-Pacific Hospital-Acquired Disease Testing Consumption Value Market Share by Type (2019-2030)
Figure 46. Asia-Pacific Hospital-Acquired Disease Testing Consumption Value Market Share by Application (2019-2030)
Figure 47. Asia-Pacific Hospital-Acquired Disease Testing Consumption Value Market Share by Region (2019-2030)
Figure 48. China Hospital-Acquired Disease Testing Consumption Value (2019-2030) & (USD Million)
Figure 49. Japan Hospital-Acquired Disease Testing Consumption Value (2019-2030) & (USD Million)
Figure 50. South Korea Hospital-Acquired Disease Testing Consumption Value (2019-2030) & (USD Million)
Figure 51. India Hospital-Acquired Disease Testing Consumption Value (2019-2030) & (USD Million)
Figure 52. Southeast Asia Hospital-Acquired Disease Testing Consumption Value (2019-2030) & (USD Million)
Figure 53. Australia Hospital-Acquired Disease Testing Consumption Value (2019-2030) & (USD Million)
Figure 54. South America Hospital-Acquired Disease Testing Consumption Value Market Share by Type (2019-2030)
Figure 55. South America Hospital-Acquired Disease Testing Consumption Value Market Share by Application (2019-2030)
Figure 56. South America Hospital-Acquired Disease Testing Consumption Value Market Share by Country (2019-2030)
Figure 57. Brazil Hospital-Acquired Disease Testing Consumption Value (2019-2030) & (USD Million)
Figure 58. Argentina Hospital-Acquired Disease Testing Consumption Value (2019-2030) & (USD Million)
Figure 59. Middle East and Africa Hospital-Acquired Disease Testing Consumption Value Market Share by Type (2019-2030)
Figure 60. Middle East and Africa Hospital-Acquired Disease Testing Consumption Value Market Share by Application (2019-2030)
Figure 61. Middle East and Africa Hospital-Acquired Disease Testing Consumption Value Market Share by Country (2019-2030)
Figure 62. Turkey Hospital-Acquired Disease Testing Consumption Value (2019-2030) & (USD Million)
Figure 63. Saudi Arabia Hospital-Acquired Disease Testing Consumption Value (2019-2030) & (USD Million)
Figure 64. UAE Hospital-Acquired Disease Testing Consumption Value (2019-2030) & (USD Million)
Figure 65. Hospital-Acquired Disease Testing Market Drivers
Figure 66. Hospital-Acquired Disease Testing Market Restraints
Figure 67. Hospital-Acquired Disease Testing Market Trends
Figure 68. Porters Five Forces Analysis
Figure 69. Manufacturing Cost Structure Analysis of Hospital-Acquired Disease Testing in 2023
Figure 70. Manufacturing Process Analysis of Hospital-Acquired Disease Testing
Figure 71. Hospital-Acquired Disease Testing Industrial Chain
Figure 72. Methodology
Figure 73. Research Process and Data Source
Figure 1. Hospital-Acquired Disease Testing Picture
Figure 2. Global Hospital-Acquired Disease Testing Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Hospital-Acquired Disease Testing Consumption Value Market Share by Type in 2023
Figure 4. UTI Testing
Figure 5. SSI Testing
Figure 6. Pneumococcal Infections Testing
Figure 7. Bloodstream Infections Testing
Figure 8. MRSA Testing
Figure 9. Global Hospital-Acquired Disease Testing Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 10. Hospital-Acquired Disease Testing Consumption Value Market Share by Application in 2023
Figure 11. Small and Medium Sized Hospitals Picture
Figure 12. Large Sized Hospitals Picture
Figure 13. Global Hospital-Acquired Disease Testing Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 14. Global Hospital-Acquired Disease Testing Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 15. Global Market Hospital-Acquired Disease Testing Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 16. Global Hospital-Acquired Disease Testing Consumption Value Market Share by Region (2019-2030)
Figure 17. Global Hospital-Acquired Disease Testing Consumption Value Market Share by Region in 2023
Figure 18. North America Hospital-Acquired Disease Testing Consumption Value (2019-2030) & (USD Million)
Figure 19. Europe Hospital-Acquired Disease Testing Consumption Value (2019-2030) & (USD Million)
Figure 20. Asia-Pacific Hospital-Acquired Disease Testing Consumption Value (2019-2030) & (USD Million)
Figure 21. South America Hospital-Acquired Disease Testing Consumption Value (2019-2030) & (USD Million)
Figure 22. Middle East and Africa Hospital-Acquired Disease Testing Consumption Value (2019-2030) & (USD Million)
Figure 23. Global Hospital-Acquired Disease Testing Revenue Share by Players in 2023
Figure 24. Hospital-Acquired Disease Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 25. Global Top 3 Players Hospital-Acquired Disease Testing Market Share in 2023
Figure 26. Global Top 6 Players Hospital-Acquired Disease Testing Market Share in 2023
Figure 27. Global Hospital-Acquired Disease Testing Consumption Value Share by Type (2019-2024)
Figure 28. Global Hospital-Acquired Disease Testing Market Share Forecast by Type (2025-2030)
Figure 29. Global Hospital-Acquired Disease Testing Consumption Value Share by Application (2019-2024)
Figure 30. Global Hospital-Acquired Disease Testing Market Share Forecast by Application (2025-2030)
Figure 31. North America Hospital-Acquired Disease Testing Consumption Value Market Share by Type (2019-2030)
Figure 32. North America Hospital-Acquired Disease Testing Consumption Value Market Share by Application (2019-2030)
Figure 33. North America Hospital-Acquired Disease Testing Consumption Value Market Share by Country (2019-2030)
Figure 34. United States Hospital-Acquired Disease Testing Consumption Value (2019-2030) & (USD Million)
Figure 35. Canada Hospital-Acquired Disease Testing Consumption Value (2019-2030) & (USD Million)
Figure 36. Mexico Hospital-Acquired Disease Testing Consumption Value (2019-2030) & (USD Million)
Figure 37. Europe Hospital-Acquired Disease Testing Consumption Value Market Share by Type (2019-2030)
Figure 38. Europe Hospital-Acquired Disease Testing Consumption Value Market Share by Application (2019-2030)
Figure 39. Europe Hospital-Acquired Disease Testing Consumption Value Market Share by Country (2019-2030)
Figure 40. Germany Hospital-Acquired Disease Testing Consumption Value (2019-2030) & (USD Million)
Figure 41. France Hospital-Acquired Disease Testing Consumption Value (2019-2030) & (USD Million)
Figure 42. United Kingdom Hospital-Acquired Disease Testing Consumption Value (2019-2030) & (USD Million)
Figure 43. Russia Hospital-Acquired Disease Testing Consumption Value (2019-2030) & (USD Million)
Figure 44. Italy Hospital-Acquired Disease Testing Consumption Value (2019-2030) & (USD Million)
Figure 45. Asia-Pacific Hospital-Acquired Disease Testing Consumption Value Market Share by Type (2019-2030)
Figure 46. Asia-Pacific Hospital-Acquired Disease Testing Consumption Value Market Share by Application (2019-2030)
Figure 47. Asia-Pacific Hospital-Acquired Disease Testing Consumption Value Market Share by Region (2019-2030)
Figure 48. China Hospital-Acquired Disease Testing Consumption Value (2019-2030) & (USD Million)
Figure 49. Japan Hospital-Acquired Disease Testing Consumption Value (2019-2030) & (USD Million)
Figure 50. South Korea Hospital-Acquired Disease Testing Consumption Value (2019-2030) & (USD Million)
Figure 51. India Hospital-Acquired Disease Testing Consumption Value (2019-2030) & (USD Million)
Figure 52. Southeast Asia Hospital-Acquired Disease Testing Consumption Value (2019-2030) & (USD Million)
Figure 53. Australia Hospital-Acquired Disease Testing Consumption Value (2019-2030) & (USD Million)
Figure 54. South America Hospital-Acquired Disease Testing Consumption Value Market Share by Type (2019-2030)
Figure 55. South America Hospital-Acquired Disease Testing Consumption Value Market Share by Application (2019-2030)
Figure 56. South America Hospital-Acquired Disease Testing Consumption Value Market Share by Country (2019-2030)
Figure 57. Brazil Hospital-Acquired Disease Testing Consumption Value (2019-2030) & (USD Million)
Figure 58. Argentina Hospital-Acquired Disease Testing Consumption Value (2019-2030) & (USD Million)
Figure 59. Middle East and Africa Hospital-Acquired Disease Testing Consumption Value Market Share by Type (2019-2030)
Figure 60. Middle East and Africa Hospital-Acquired Disease Testing Consumption Value Market Share by Application (2019-2030)
Figure 61. Middle East and Africa Hospital-Acquired Disease Testing Consumption Value Market Share by Country (2019-2030)
Figure 62. Turkey Hospital-Acquired Disease Testing Consumption Value (2019-2030) & (USD Million)
Figure 63. Saudi Arabia Hospital-Acquired Disease Testing Consumption Value (2019-2030) & (USD Million)
Figure 64. UAE Hospital-Acquired Disease Testing Consumption Value (2019-2030) & (USD Million)
Figure 65. Hospital-Acquired Disease Testing Market Drivers
Figure 66. Hospital-Acquired Disease Testing Market Restraints
Figure 67. Hospital-Acquired Disease Testing Market Trends
Figure 68. Porters Five Forces Analysis
Figure 69. Manufacturing Cost Structure Analysis of Hospital-Acquired Disease Testing in 2023
Figure 70. Manufacturing Process Analysis of Hospital-Acquired Disease Testing
Figure 71. Hospital-Acquired Disease Testing Industrial Chain
Figure 72. Methodology
Figure 73. Research Process and Data Source
